REGN6490

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

Healthy Volunteer

Phase 1

Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers

TerminatedNCT04616079

Regeneron PharmaceuticalsHealthy Volunteer

Start: 2020-11-19End: 2021-06-01Updated: 2021-11-11

Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers

TerminatedNCT04616105

Regeneron PharmaceuticalsHealthy Volunteer

Start: 2020-11-18End: 2021-05-28Updated: 2021-11-11